A schematic review on multifaceted relationship between cardiovascular disease and diabetes

Hem Shanker Sharma; Sumit Shanker

doi:10.18203/2320-6012.ijrms20233826

Authors

Hem Shanker Sharma Department of Medicine, Jawahar Lal Nehru Medical College and Hospital, Bhagalpur, Bihar, India
Sumit Shanker Department of Medicine, Jawahar Lal Nehru Medical College and Hospital, Bhagalpur, Bihar, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20233826

Keywords:

Diabetes mellitus, Type 2 diabetes mellitus, CVD, Mortality rate

Abstract

Cardiovascular disease (CVD) and diabetes mellitus are health conditions that are closely linked and have a significant impact, on public health systems and personal well-being. The intersection of these two conditions has generated concerns, within the healthcare field and medical research. The importance of understanding the connection, between disease and diabetes cannot be highlighted enough. Diabetes is a chief risk element to the development and progression of state such as peripheral vascular disease, coronary artery disease, and stroke. Individuals with diabetes face a 2 to 4 folds risk of experiencing events as equated to those without diabetes. This simultaneous occurrence of these two health issues has implications, for healthcare professionals, policymakers and the individuals affected by them. Despite the progress made in managing both CVD and diabetes it remains crucial to address the overlap, between these two conditions. The matter, at hand revolves around comprehending the links between these two conditions identifying effective methods, for prevention and treatment and maximizing patient care. It is crucial, for healthcare professionals, policymakers and people who have CVD or diabetes to understand how these two conditions interact with each other. In this review our goal is to present an overview of the multifaceted relationship between CVD and diabetes.

Metrics

Metrics Loading ...

References

Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-621.

Huang H, Liu J, Liang X, Fang L, Yang C, Ke K et al. Trends in the prevalence of elevated cardiovascular risk and the control of its risk elements Among US adults, 2001-2020. Front Cardiovasc Med. 2023;10:1153926.

World Heart Federation, 2023. World Heart Report 2023: Confronting the World’s Number One Killer. 2023.

Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):2932-8.

International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation. 2019.

Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Eng J Med. 1998;339(4):229-34.

National Cholesterol Education Program (US). Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (No. 2). The Program. 2002.

Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E et al. Emerging Risk elements Collaboration Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-22.

Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O et al. Diabetes as a cardiovascular risk element: An overview of global trends of macro and micro vascular complications. Eur J Prevent Cardiol. 2019;26(2):25-32.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20.

Rana JS, Liu JY, Moffet HH, Jaffe M, Karter AJ. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events. J General Internal Med. 2016;31:387-93.

Kramer CK, Zinman B, Gross JL, Canani LH, Rodrigues TC, Azevedo MJ et al. Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ. 2013;346.

Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2014;43(9):1663-1669.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315.

Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metabolic Syndrome 2017;9:1-13.

Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368(9529):29-36.

Li R, O'Sullivan MJ, Robinson J, Safford MM, Curb D, Johnson KC. Family history of myocardial infarction predicts incident coronary heart disease in postmenopausal women with diabetes: the Women's Health Initiative Observational Study. Diabetes/ Metabol Res Rev. 2009;25(8):725-32.

Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O’Leary D et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA, 2012;308(8):788-95.

Goff Jr DC, Lloyd-Jones DM, Bennett G, Coady S, D’agostino RB, Gibbons R et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25-2):S49-73.

Qin R, Chen T, Lou Q, Yu D. Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol. 2013;167(2):342-50.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20.

Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89-92.

American Diabetes Association. Standards of medical care in diabetes-2017: summary of revisions. Diabetes Care. 2017;40(1):S4.

Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (London, England). 2008;371(9607):117-25.

Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha Fernandes JD, Ohlrogge AW et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81.

Ballotari P, Ranieri SC, Luberto F, Caroli S, Greci M, Giorgi Rossi P et al. Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy). Int J Endocrinol. 2015.

Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S et al. Excess mortality among persons with type 2 diabetes. N Eng J Med. 2015;373(18):1720-32.

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular Diabetol. 2008;17(1):1-19.

Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018;391(10138):2430-40.

Meza R, Barrientos-Gutierrez T, Rojas-Martinez R, Reynoso-Noverón N, Palacio-Mejia LS, Lazcano-Ponce, E et al. Burden of type 2 diabetes in Mexico: past, current and future prevalence and incidence rates. Preventive Med. 2015;81:445-50.

Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Colle Cardiol. 2002;40(5):946-53.

Tandon N, Anjana RM, Mohan V, Kaur T, Afshin A, Ong K et al. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990-2016. Lancet Global Heal. 2018;6(12):e1352-62.